IRIS UniCatt

Fresa, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.146
NA - Nord America 916
EU - Europa 699
SA - Sud America 314
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 867
SG - Singapore 537
CN - Cina 283
BR - Brasile 247
IT - Italia 218
DE - Germania 114
SE - Svezia 86
IN - India 81
FR - Francia 68
VN - Vietnam 67
FI - Finlandia 51
ID - Indonesia 39
IE - Irlanda 33
GB - Regno Unito 30
KR - Corea 30
AR - Argentina 28
CA - Canada 26
RU - Federazione Russa 24
MX - Messico 20
BD - Bangladesh 17
HK - Hong Kong 15
AT - Austria 13
EC - Ecuador 12
JP - Giappone 12
NL - Olanda 12
ZA - Sudafrica 12
PL - Polonia 11
TR - Turchia 11
CO - Colombia 10
CZ - Repubblica Ceca 10
IQ - Iraq 9
ES - Italia 8
VE - Venezuela 5
BE - Belgio 4
DZ - Algeria 4
IL - Israele 4
IR - Iran 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
LB - Libano 3
MA - Marocco 3
NP - Nepal 3
QA - Qatar 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EG - Egitto 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
RO - Romania 2
UA - Ucraina 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
OM - Oman 1
PH - Filippine 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 3.110
Salva come PNG Salva come JPEG
Città #
Singapore 284
Ashburn 109
Chandler 80
Hefei 76
Rome 72
Beijing 60
Hyderabad 53
Los Angeles 45
New York 44
Chicago 40
Florence 36
Munich 36
Frankfurt am Main 33
Jakarta 33
Dublin 31
Seoul 30
Ho Chi Minh City 28
Milan 28
Dallas 23
Turku 23
Kent 22
São Paulo 16
The Dalles 16
Lappeenranta 15
Nuremberg 15
Buffalo 14
Hanoi 13
Helsinki 13
Moscow 13
Rio de Janeiro 13
Boston 12
Hong Kong 12
Montreal 12
Santa Clara 12
Tampa 12
Tokyo 12
Bremen 11
Princeton 11
Phoenix 10
Salt Lake City 10
Atlanta 9
Brooklyn 9
Düsseldorf 9
Stockholm 9
Vienna 9
Wilmington 9
Denver 8
San Mateo 8
Elk Grove Village 7
Johannesburg 7
Marseille 7
Naples 7
Poplar 7
Brno 6
Lauterbourg 6
London 6
Toronto 6
Warsaw 6
Washington 6
Belo Horizonte 5
Bogotá 5
Buenos Aires 5
Campinas 5
Chennai 5
Curitiba 5
Dulles 5
Guayaquil 5
Manchester 5
North Hollywood 5
Orem 5
Pavia 5
Amsterdam 4
Brasília 4
Brdo 4
Brussels 4
Council Bluffs 4
Manaus 4
Mexico City 4
New Delhi 4
Paris 4
Porto Alegre 4
Turin 4
Ankara 3
Arezzo 3
Baghdad 3
Bexley 3
Canoas 3
Central 3
Charlotte 3
Colombo 3
Dhaka 3
Doha 3
Fairfield 3
Goiânia 3
Greenville 3
Guangzhou 3
Guarulhos 3
Haiphong 3
Hortolândia 3
Juneau 3
Totale 1.727
Salva come PNG Salva come JPEG
Nome #
Role of microRNAs in Chronic Lymphocytic Leukemia 140
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 121
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 113
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 102
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 101
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 100
the concomitance of lymphoma and breast carcinoma in the bone 99
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 95
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 86
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 84
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 84
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 83
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 83
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 82
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 81
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 80
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 80
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 79
Richter transformation in Chronic Lymphocytic Leukemia 77
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 77
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 77
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 77
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 75
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 71
The concomitance of lymphoma and breast carcinoma in the bone 71
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 70
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 68
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 68
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 64
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 63
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 63
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed 61
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 61
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature 61
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 60
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 59
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study 57
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 56
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study 54
CAR-T Cells in Chronic Lymphocytic Leukemia 52
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 17
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort 12
Measurable residual disease in chronic lymphocytic leukemia 8
Totale 3.172
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 2 0 2 0 3 0
2021/202282 0 3 3 2 7 0 1 9 5 0 34 18
2022/2023290 34 34 13 31 25 25 12 20 45 17 31 3
2023/2024363 6 64 22 37 15 55 31 21 2 26 31 53
2024/20251.088 21 19 57 55 65 39 44 27 93 122 373 173
2025/20261.324 299 98 181 288 345 113 0 0 0 0 0 0
Totale 3.172